Apogee Therapeutics, Inc.
APGE
$82.93
-$1.67-1.97%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
5/12/2026
-
TipRanks Financial Blog
Analysts Offer Insights on Healthcare Companies: Oculis Holding (OCS) and Apogee Therapeutics (APGE)
5/12/2026
-
TipRanks Financial Blog
5/11/2026
-
The Cerbat Gem
5/11/2026
-
MarketBeat
5/11/2026
-
TipRanks Financial Blog
5/11/2026
-
Globe Newswire
5/10/2026
-
MarketBeat
5/9/2026
-
The Cerbat Gem
5/9/2026
-
MarketBeat
5/5/2026
-
Simply Wall St
5/4/2026
-
MarketBeat
5/2/2026
-
MarketBeat
5/2/2026
-
MarketBeat
5/1/2026
-
MarketBeat
4/29/2026
-
Tickeron - Stocks
4/27/2026
-
Insider Monkey
4/27/2026
-
Yahoo! Finance: News
4/26/2026
-
Insider Monkey
4/25/2026
-
Tickeron - Technical Analysis
4/24/2026
-
TipRanks Financial Blog
4/24/2026
-
Tickeron - Stocks
4/23/2026
-
Tickeron - Technical Analysis
4/22/2026
-
Tickeron - Stocks
4/21/2026
-
Tickeron - Stocks
4/15/2026
-
MarketBeat
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, May 11, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
Week of Aug 10 and 14 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
650 394 5230
Address
Building 17
Suite 102b - 221 Crescent Street
Waltham, MA 02453
Suite 102b - 221 Crescent Street
Waltham, MA 02453
Country
Year Founded
Business Description
Sector
Apogee Therapeutics, Inc., a clinical stage biotechnology company, develops novel biologics for the treatment of atopic dermatitis, asthma, eosinophilic esophagitis, chronic obstructive pulmonary...
more